Autolus Therapeutics PLC (NAS:AUTL)
$ 3.92 0.05 (1.29%) Market Cap: 1.04 Bil Enterprise Value: 335.67 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Q3 2022 Autolus Therapeutics PLC Earnings Call Transcript

Nov 03, 2022 / 12:30PM GMT
Release Date Price: $2.64 (-5.04%)
Operator

Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2022 Financial Results Conference Call. As a reminder, this conference call is being recorded. And I'd like to now turn the conference over to your host, Olivia Manser, Director of Investor Relations. Please go ahead.

Olivia Manser;Director
Investor Relations,

Thanks, Breanna. Good morning or good afternoon, everyone, and thanks for joining us to take part in today's call on the financial results and operational highlights for the third quarter for Autolus. I'm Olivia Manser, Director of Investor Relations. And with me on today's call, as usual, are Dr. Christian Itin, our Chief Executive Officer; and Dr. Lucinda Crabtree, our Chief Financial Officer.

So before we begin, I'd just like to remind you as usual that during today's call, our discussion will contain forward-looking statements. Please make sure you are familiar with our disclaimer slide, which is on Slide 2. And then turning to Slide 3, you'll see the agenda for today, which is as follows.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot